Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Findings from the United States advance knowledge in HIV/AIDS research
May 10th, 2006
Reports from the United States highlight recent research in HIV/AIDS. Study 1: Prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag attenuated simian immunodeficiency virus SIVmac239 infection. Scientists writing in the Journal of Virology report, "The prophylactic efficacy of DNA and replication-incompetent adenovirus serotype 5 (Ad5) vaccine vectors expressing simian immunodeficiency virus (SIV) Gag was examined in rhesus macaques using an SlVmac239 challenge." "Cohorts of either Mamu-A*01+ or Mamu-A*01- macaques were immunized with a DNA prime-Ad5 boost regimen; for comparison, a...
Source: Vaccine Weekly (2006-05-10)
|
